Folia Parasitologica 57[2] 105-113 (2010) | DOI: 10.14411/fp.2010.013

Toxoplasmosis as a cause for behaviour disorders - overview of evidence and mechanisms

Abebaw Fekadu1,2, Teshome Shibre1, Anthony J. Cleare2
1 Department of Psychiatry, Faculty of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
2 King's College London, Institute of Psychiatry, Department of Psychological Medicine and Psychiatry, London, UK

Background - There is growing interest in the role of microbial agents in the causation of psychiatric disorders. The neurotropic protozoan parasite Toxoplasma gondii is one of the main candidates and has been associated with various psychiatric conditions, including schizophrenia. Methods - A narrative review of the literature from the main medical databases (Medline, PubMed, PsycINFO), Google Scholar and Google using combinations of applicable terms. Results - T. gondii affects the brain in both the acute and the latent stages of infection causing apparent brain pathologies in infected rodents and both immuno-compromised and immuno-competent humans. In immuno-competent individuals, behavioural disorders are primarily related to the latent stages of the illness. Behavioural/mental disorders that include schizophrenia, mood disorders, personality changes and cognitive impairments may be related to infection with T. gondii. Evidence for a behavioural effect of T. gondii comes from observational reports in animal models and controlled behavioural analysis in humans. Indirect clues of infection also come from raised seroprevalence or serotitres of antitoxoplasma antibodies among those with mental disorders. The pathophysiologic mechanism through which T. gondii may exert its effect is not clear, but direct impact on the brain and changes in neuroimmunomodulation, neurotransmission and some gene-environment interactions are postulated. Conclusion - There is evidence supporting a potential role of T. gondii infection in the onset of some behavioural disorders. Confirmation of such a role would prove a significant breakthrough in the search for the aetiology, treatment and prevention of behavioural disorders, such as schizophrenia. However, the associations remain preliminary.

Keywords: toxoplasmosis, Toxoplasma gondii, behavioural disorder, personality changes, schizophrenia, mood disorders, review

Received: January 19, 2010; Accepted: May 5, 2010; Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Fekadu, A., Shibre, T., & Cleare, A.J. (2010). Toxoplasmosis as a cause for behaviour disorders - overview of evidence and mechanisms. Folia Parasitologica, 57(2), 105-113. doi: 10.14411/fp.2010.013
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adkesson M.J., Gorman M.E., Hsiao V., Whittington J.K., Langan J.N. 2007: Toxoplasma gondii inclusions in peripheral blood leukocytes of red-necked wallaby (Macropus rufogriseus). Vet. Clin. Pathol. 36: 97-100 Go to original source... Go to PubMed...
    2. Alvarado -Esquivel C., Alanis -Quinones O.P., ArreolaValenzuela M.A., Rodriguez -Briones A., Piedra-Nevarez L.J., Duran -Morales E., Estrada-Martinez S., Martinez Garcia S.A., Liesenfeld O. 2006: Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect. Dis. 6: e178 Go to original source... Go to PubMed...
    3. Amminger G.P., Mc Gorry P.D., Berger G.E., Wade D., Yung A.R., Phillips L.J., Harrigan S.M., Francey S.M., Yolken R.H. 2007: Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol. Psychiat. 61: 1215-1217 Go to original source... Go to PubMed...
    4. Arling T., Yolken R.H., Lapidus M., Langenberg P., Dickerson F.B., Zimmerman S.A., Balis T., Cabassa J.A., Scran dis D.A., Tonelli L.H., Postolache T.T. 2009: Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J. Nerv. Ment. Dis. 197: 905-908 Go to original source... Go to PubMed...
    5. Bachmann S., Schroder J., Bottmer C., Torrey E.F., Yolken R.H. 2005: Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii. Psychopathol. 38: 87-90 Go to original source... Go to PubMed...
    6. Basso W., More G., Quiroga M.A., Pardini L., Bacigalupe D., Venturini L., Valenzuela M.C., Balducchi D., Maksimov P., Schares G., Venturini M.C. 2009: Isolation and molecular characterization of Toxoplasma gondii from captive slendertailed meerkats (Suricata suricatta) with fatal toxoplasmosis in Argentina. Vet. Parasitol. 161: 201-206 Go to original source... Go to PubMed...
    7. Brown A.S., Schaefer C.A., Quesenberry C.P., Jr., Liu L., Babulas V.P., Susser E.S. 2005: Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am. J. Psychiat. 162: 767-773 Go to original source... Go to PubMed...
    8. Brown A.S., Vinogradov S., Kremen W.S., Poole J.H., Deicken R.F., Penner J.D., Mc Keague I.W., Kochetkova A., Kern D., Schaefer C.A. 2009: Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am. J. Psychiat. 166: 683-690 Go to original source... Go to PubMed...
    9. Brynska A. 2001: Obsessive-compulsive disorder and acquired toxoplasmosis in two children. Eur. Child Adolesc. Psychiat. 10: 200-204 Go to original source...
    10. Carruthers V.B., Suzuki Y. 2007: Effects of Toxoplasma gondii infection on the brain. Schizophr. Bull. 33: 745-751 Go to original source... Go to PubMed...
    11. Cetinkaya Z., Yazar S., Gecici O., Namli M.N. 2007: AntiToxoplasma gondii antibodies in patients with schizophrenia - preliminary findings in a Turkish sample. Schizophr. Bull. 33: 789-791 Go to original source... Go to PubMed...
    12. Delgado G.G., Rodriguez P.E. 1980: Reactivity of toxoplasmin intradermal test in neurotic and manic-depressive patients. Rev. Cuba. Med. Trop. 32: 35-39
    13. Demyttenaere K., Bruffaerts R., Posada-Villa J., Gasquet I., Kovess V., Lepine J.P., Angermeyer M.C., Bernert S., de Girolamo G., Morosini P., Polidori G., Kikkawa T., Kawakami N., Ono Y., Takeshima T., Uda H., Karam E.G., Fayyad J.A., Karam A.N., Mneimneh Z.N., Medina-Mora M.E., Borges G., Lara C., de Graaf R., Ormel J., Gureje O., Shen Y., Huang Y., Zhang M., Alonso J., Haro J.M., Vi lagut G., Bromet E.J., Gluzman S., Webb C., Kessler R.C., Merikangas K.R., Anthony J.C., Von Korff M.R., Wang P.S., Brugha T.S., Aguilar-Gaxiola S., Lee S., Heeringa S., Pennell B.E., Zaslavsky A.M., Ustun T.B., Chatterji S.; WHO World M ental H ealth Survey C onsortium 2004: Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA (J. Am. Med. Assoc.) 291: 2581-2590
    14. Dickerson F., Boronow J., Stallings C., Origoni A., Yolken R. 2007: Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality. Schizophr. Bull. 33: 737-740 Go to original source... Go to PubMed...
    15. Dickerson F.B., Stallings C.R., Boronow J.J., Origoni A.E., Yolken R.H. 2009: A double-blind trial of adjunctive azithromycin in individuals with schizophrenia who are seropositive for Toxoplasma gondii. Schizophr. Res. 112: 198-199 Go to original source... Go to PubMed...
    16. Dogruman -Al F., Asian S., Yalcin S., Kustimur S., Turk S. 2009: A possible relationship between Toxoplasma gondii and schizophrenia: a seroprevalence study. Int. J. Psychiat. Clin. Pract. 13: 82-87 Go to original source... Go to PubMed...
    17. Dunn A.J. 2006: Effects of cytokines and infections on brain neurochemistry. Clin. Neurosci. Res. 6: 52-68 Go to original source... Go to PubMed...
    18. El -Sahn A.A., Shatat H.Z., Ghitany E.M. 2005: Seropositivity of toxoplasmosis in patients with schizophrenia. J. Egypt. Public Health Assoc. 80: 509-524 Go to PubMed...
    19. Fallon B.A. 2009: Neuropsychiatric aspects of other infectious diseases (Non-HIV). In: B.J. Sadock, V.A. Sadock and P. Ruiz (Eds.), Kaplan & Sadock's Comprehensive Textbook of Psychiatry. 9th Ed., Vol 1. Philadelphia, Lippincott Williams & Wilkins, 532 pp
    20. Ferguson D.J., Hutchison W.M. 1987: The host-parasite relationship of Toxoplasma gondii in the brains of chronically infected mice. Virchows Arch. A. Pathol. Anat. Histopathol. 411: 39-43 Go to original source... Go to PubMed...
    21. Flegr J. 2007: Effects of Toxoplasma on human behavior. Schizophr. Bull. 33: 757-760 Go to original source... Go to PubMed...
    22. Flegr J., Havlicek J., Kodym P., Maly M., Smahel Z. 2002: Increased risk of traffic accidents in subjects with latent toxo plasmosis: a retrospective case-control study. BMC Infect. Dis. 2: e11 Go to original source... Go to PubMed...
    23. Flegr J., Klose J., Novotna M., Berenreitterova M., Havlicek J. 2009: Increased incidence of traffic accidents in Toxoplasmainfected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study. BMC Infect. Dis. 9: e72 Go to original source... Go to PubMed...
    24. Flegr J., Kodym P., Tolarova V. 2000: Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol. Psychol. 53: 57-68 Go to original source... Go to PubMed...
    25. Flegr J., Preiss M., Klose J., Havlicek J., Vitakova M., Kodym P. 2003: Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii. Dopamine, a missing link between schizophrenia and toxoplasmosis? Biol. Psychol. 63: 253-268 Go to original source... Go to PubMed...
    26. Flegr J., Zitkova S., Kodym P., Frynta D. 1996: Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 113: 49-54 Go to original source... Go to PubMed...
    27. Gaskell E.A., Smith J.E., Pinney J.W., Westhead D.R., Mc Co nkey G.A. 2009: A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS ONE 4: e4801 Go to original source... Go to PubMed...
    28. Halonen S.K., Lyman W.D., Chiu F.C. 1996: Growth and development of Toxoplasma gondii in human neurons and astrocytes. J. Neuropathol. Exp. Neurol. 55: 1150-1156 Go to original source... Go to PubMed...
    29. Henriquez S.A., Brett R., Alexander J., Pratt J., Roberts C.W. 2009: Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 16: 122-133 Go to PubMed...
    30. Hinze -Selch D., Daeubener W., Eggert L., Erdag S., Stolten berg R., Wilms S. 2007: A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr. Bull. 33: 782-788 Go to original source... Go to PubMed...
    31. Holliman R.E. 1997: Toxoplasmosis, behavior and personality. J. Infect. 35: 105-110 Go to original source... Go to PubMed...
    32. Israelski D.M., Remington J.S. 1988: Toxoplasmic encephalitis in patients with AIDS. Infect. Dis. Clin. North Am. 2: 429-445 Go to original source... Go to PubMed...
    33. Jones -Brando L., Torrey E.F., Yolken R. 2003: Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr. Res. 62: 237-244 Go to original source... Go to PubMed...
    34. Kar N., Misra B. 2004: Toxoplasma seropositivity and depression: a case report. BMC Psychiat. 4: e1 Go to original source... Go to PubMed...
    35. Kay S.R., Fiszbein A., Opler L.A. 1987: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13: 261-276 Go to original source... Go to PubMed...
    36. Kim J.H., Kang K.I., Kang W.C., Sohn H.J., Jean Y.H., Park B.K., Kim Y., Kim D.Y. 2009: Porcine abortion outbreak associated with Toxoplasma gondii in Jeju Island, Korea. J. Vet. Sci. 10: 147-151 Go to original source... Go to PubMed...
    37. Kohn R., Saxena S., Levav I., Saraceno B. 2004: Treatment gap in mental health care. Bull. WHO 82: 858-866
    38. Leweke F.M., Gerth C.W., Koethe D., Klosterkotter J., Ruslanova I., Krivogorsky B., Torrey E.F., Yolken R.H. 2004: Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur. Arch. Psychiat. Clin. Neurosci. 254: 4-8 Go to original source... Go to PubMed...
    39. Montoya J.G., Liesenfeld O. 2004: Toxoplasmosis. Lancet 363: 1965-1976 Go to original source... Go to PubMed...
    40. Mortensen P.B., Norgaard -Pedersen B., Waltoft B.L., So rensen T.L., Hougaard D., Yolken R.H. 2007a: Early infection of Toxoplasma gondii and the later development of schizophrenia. Schizophr. Bull. 33: 741-744 Go to original source... Go to PubMed...
    41. Mortensen P.B., Norgaard -Pedersen B., Waltoft B.L., So rensen T.L., Hougaard D., Torrey E.F., Yolken R.H. 2007b: Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol. Psychiat. 61: 688-693 Go to original source... Go to PubMed...
    42. Muller N., Schwartz M.J. 2007a: The immune-mediated alteration of serotonin and glutamate towards an integrated view of depression. Mol. Psychiat. 12: 988-1000 Go to original source... Go to PubMed...
    43. Muller N., Schwartz M.J. 2007b: The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J. Neural Transm. 72 (Suppl.): 269-280 Go to original source... Go to PubMed...
    44. Niebuhr D.W., Millikan A.M., Cowan C.N., Yolken R., Li Y., Weber N.S. 2008: Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am. J. Psychiat. 165: 99-106 Go to original source... Go to PubMed...
    45. Novotna M., Havlicek J., Smith A.P., Kolbekova P., Skallova A., Klose J., Gasova Z., Pisacka M., Sechovska M., Flegr J. 2008: Toxoplasma and reaction time: role of toxoplasmosis in the origin, preservation and geographical distribution of Rh blood group polymorphism. Parasitology 135: 1253-1261 Go to original source... Go to PubMed...
    46. Shibre T., Alem A., Abdulahi A., Araya M., Beyero T., Me dhin G., Deyassa N., Negash N., Nigatu A., Kebede D., Fekadu A. 2009: Trimethoprim as adjuvant treatment in schizophrenia: A double-blind, randomized, placebo-controlled clinical trial. Schizophr. Bull. doi: 10.1093/schbul/sbn191 Go to original source... Go to PubMed...
    47. Sims T.A., Hay J., Talbot I.C. 1989: An electron microscope and immunohistochemical study of the intracellular Toxoplasma tissue cysts within the brain of mice with congenital toxoplasmosis. Br. J. Exp. Pathol. 70: 317-325
    48. Skallova A., Novotna M., Kolbekova P., Gasova Z., Vesely V., Sechovska M., Flegr J. 2005: Decreased level of novelty seeking in blood donors infected with Toxoplasma. Neuroendocrinol. Lett. 26: 480-486 Go to PubMed...
    49. Tamer G.S., Dundar D., Yalug I., Caliskan S., Yazar S., Aker A. 2008: The schizophrenia and Toxoplasma gondii connection: infectious, immune or both? Adv. Ther. 25: 703-709 Go to original source... Go to PubMed...
    50. Thomas H.V., Thomas D.R., Salmon R.L., Lewis G., Smith A.P. 2004: Toxoplasma and Coxiella infection and psychiatric morbidity: a retrospective cohort analysis. BMC Psychiat. 4: e32 Go to original source... Go to PubMed...
    51. Torrey E.F., Bartko J.J., Lun Z.-R., Yolken R.H. 2007: Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr. Bull. 33: 729-736 Go to original source... Go to PubMed...
    52. Torrey E.F., Yolken R.H. 2003: Toxoplasma gondii and schizophrenia. Emerg. Infect. Dis. 9: 1375-1380 Go to original source... Go to PubMed...
    53. Vyas A., Kim S.K., Giacomini N., Boothroyd J.C., Sapolsky R.M. 2007: Behavioral changes induced by T. gondii infection of rodents are highly specific to aversion of cat odors. Proc. Natl. Acad. Sci. U. S. A. 104: 6442-6447 Go to original source... Go to PubMed...
    54. Wang H.-L., Wang G.-H., Li Q.-Y., Shu C., Jiang M.S., Guo Y. 2006: Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr. Scand. 114: 40-48 Go to original source... Go to PubMed...
    55. Wang P.S., Aguilar-Gaxiola S., Alonso J., Angermeyer M.C., Borges G., Bromet E.J., Bruffaerts R., de Girolamo G., de Graaf R., Gureje O., Haro J.M., Karam E.G., Kessler R.C., Kovess V., Lane M.C., Lee S., Levinson D., Ono Y., Petukhova M., Posada-Villa J., Seedat S., Wells J.E. 2007: Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 370: 841-850 Go to original source... Go to PubMed...
    56. Webster J.P. 2007: The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophr. Bull. 33: 752-756 Go to original source... Go to PubMed...
    57. Webster J.P., Lamberton P.H., Donnelly C.A., Torrey E.F. 2006: Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and antiparasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc. R. Soc. Lond., Ser. B, 273: 1023-1030 Go to original source... Go to PubMed...
    58. Wolf A., Cowen D., Paige B.H. 1939: Human toxoplasmosis. Science 89: 226-227 Go to original source... Go to PubMed...
    59. World H ealth O rganisation 2001: World Health Report 2001. Mental Health: New Understanding, New Hope. World Health Organisation, Geneva, 178 pp
    60. Xiao J., Buka S.L., Cannon T.D., Suzuki Y., Viscidi R.P., Torrey E.F., Yolken R.H. 2009: Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. Microbes Infect. 11: 1011-1018 Go to original source... Go to PubMed...
    61. Yereli K., Balcioglu I.C., Ozbilgin A. 2006: Is Toxoplasma gondii a potential risk for traffic accidents in Turkey? Forensic Sci. Int. 163: 34-37 Go to original source... Go to PubMed...
    62. Zammit S., Allebeck P., Andreasson S., Lundberg I., Lewis G. 2002: Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Bri. Med. J. 325: 1199-1201 Go to original source... Go to PubMed...
    63. Zhu S. 2009: Psychosis may be associated with toxoplasmosis. Med. Hypotheses 73: 799-801 Go to original source... Go to PubMed...
    64. Zhu S., Du Y., Li Q., Dong Z. 2007b: High risk of psychosis may be associated with toxoplasmosis. Life Sci. J. 4: 38-41
    65. Zhu S., Guo M.F., Feng Q.C., Fan J.M., Zhang L-X. 2007a: Epidemiological evidences from China assume that psychiatric-related diseases may be associated with Toxoplasma gondii infection. Neuroendocrinol. Lett. 28: 115-120 Go to PubMed...

    Return to the content